Kanabo Group KNB, a health-tech company focused on patient care with its innovative digital healthcare platform and medical cannabis treatment portfolio, announced Ian Mattioli's appointment as chair of the board.
The £2.5 million ($3.15 million) minimum investment round includes an institutional investor, company management, and Ian Mattioli's £500,000 investment. This funding will support Kanabo's UK market expansion, further developing its telehealth offering, and accelerating the integration of additional treatments into its digital health platform and medical cannabis product line.
David Tsur, Kanabo's outgoing chair, welcomed Mattioli to the leadership team, stating:
"We are pleased to have Ian Mattioli join us at this pivotal time for Kanabo. His appointment will substantially boost our expansion plans in the digital healthcare sector. Ian's experience and understanding of London's capital markets will be invaluable as we work to advance our strategic goals. Since our admission to the London Stock Exchange, we have achieved several significant milestones, including experiencing considerable revenue growth, launching two medical cannabis products, building a comprehensive supply chain, acquiring The GP Service, and launching Treat-It, our innovative digital health platform for pain management."
Mattioli stated: "I am honored to join Kanabo at this pivotal moment in the company's journey. As they aim to become a leader in the digital healthcare sector, Kanabo is well-positioned to address the growing need for accessible and specialized medications. The unique end-to-end healthcare solution enables patients to take control of their personalized care and improve their overall health. I see great potential in Kanabo's innovative approach, the significant market opportunity in the digital health arena, and the rising demand for medicinal cannabis products, setting the foundation for solid growth and success in the coming years."
Photo: Benzinga edit with photos by geralt, lindsayfox on Pixabay
Related News
Kanabo Launches eCommerce Platform For Wellness CBD Consumers In UK, Europe Soon
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.